These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 790476)

  • 21. Correlations between P300 components and neurotransmitters in the cerebrospinal fluid.
    Mochizuki Y; Oishi M; Takasu T
    Clin Electroencephalogr; 1998 Jan; 29(1):7-9. PubMed ID: 9472419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the metabolism of hypothalamic norepinephrine associated with the onset of maternal behavior in the nulliparous rat.
    Rosenberg P; Leidahl L; Halaris A; Moltz H
    Pharmacol Biochem Behav; 1976 Jun; 4(6):647-9. PubMed ID: 790399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders.
    Yamada S; Yamauchi K; Yajima J; Hisadomi S; Maeda H; Toyomasu K; Tanaka M
    Psychiatry Res; 2000 Apr; 93(3):217-23. PubMed ID: 10760380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3-Methoxy-4 -hydroxyphenylglycol (MHPG)].
    Yoneda M; Sanada H
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():426-8. PubMed ID: 20960809
    [No Abstract]   [Full Text] [Related]  

  • 25. Free 3-methoxy-4-hydroxyphenylethyleneglycol in the central nervous system of the rat: semi-automated fluorometric assay, turnover and effects of drugs.
    Adèr JP; Korf J
    J Neurochem; 1979 Jun; 32(6):1761-8. PubMed ID: 376782
    [No Abstract]   [Full Text] [Related]  

  • 26. N-acetylaspartic acid (NAA) and N-acetylaspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid.
    Faull KF; Rafie R; Pascoe N; Marsh L; Pfefferbaum A
    Neurochem Res; 1999 Oct; 24(10):1249-61. PubMed ID: 10492520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of probenecid on levels of cyclic AMP in human cerebrospinal fluid.
    Cramer H; Ng LK; Chase TN
    J Neurochem; 1972 Jun; 19(6):1601-2. PubMed ID: 4338441
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of probenecid and exercise on cerebrospinal-fluid cyclic A.M.P. in affective illness.
    Cramer H; Goodwin FK; Post RM; Bunney WE
    Lancet; 1972 Jun; 1(7764):1346-7. PubMed ID: 4113445
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of probenecid on spontaneous motor activity in rats.
    Lyness WH; Mycek MJ
    Neuropharmacology; 1978 Mar; 17(3):211-3. PubMed ID: 643165
    [No Abstract]   [Full Text] [Related]  

  • 30. Probenecid inhibition of methotrexate excretion from cerebrospinal fluid in dogs.
    Ramu A; Glaubiger D; Ramu NP; Eldridge N; Blaschke TF
    J Pharmacokinet Biopharm; 1978 Oct; 6(5):389-97. PubMed ID: 731407
    [No Abstract]   [Full Text] [Related]  

  • 31. The formation of 3, 4-dihydroxyphenylethanol and 3-methoxy-4-hydroxyphenylethanol from 3, 4-dihydroxy-phenylethylamine in the rat.
    GOLDSTEIN M; FRIEDHOFF AJ; POMERANTZ S; CONTRERA JF
    J Biol Chem; 1961 Jun; 236():1816-21. PubMed ID: 13706661
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid liquid chromatographic determination of probenecid in human cerebrospinal fluid.
    Hsieh JY; Davis KL
    J Chromatogr; 1981 Oct; 225(2):521-5. PubMed ID: 7298787
    [No Abstract]   [Full Text] [Related]  

  • 33. Improved sample preparation before liquid-chromatographic determination of probenecid in cerebrospinal fluid.
    Hsieh JY; Yang RK; Davis KL
    Clin Chem; 1983 Jan; 29(1):213-4. PubMed ID: 6848272
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental changes in liver function induced by probenecid.
    GOETZEE AE; RICHARDS TG; TINDALL VR
    Clin Sci; 1960 Feb; 19():63-78. PubMed ID: 13850452
    [No Abstract]   [Full Text] [Related]  

  • 35. Determination of probenecid in small volumes of cerebrospinal fluid.
    Watson F; Wilk S
    J Neurochem; 1973 Dec; 21(6):1569-71. PubMed ID: 4771447
    [No Abstract]   [Full Text] [Related]  

  • 36. Enzyme-inducing properties of probenecid in man.
    Bammel A; Mönig H; Zurborn KH; Ohnhaus EE; Kirch W
    Br J Clin Pharmacol; 1991 Jan; 31(1):120-1. PubMed ID: 2015165
    [No Abstract]   [Full Text] [Related]  

  • 37. NEW and nonofficial remedies; probenecid.
    J Am Med Assoc; 1953 Jan; 151(4):298. PubMed ID: 12999560
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the detection of 3-methoxy-4-hydroxyphenylethanol in human cerebrospinal fluid.
    Wilk S
    Biochem Pharmacol; 1971 Aug; 20(8):2095-6. PubMed ID: 5137968
    [No Abstract]   [Full Text] [Related]  

  • 39. Origin of free 3-methoxy-4-hydroxyphenylethyleneglycol.
    Adèr JP; Aizenstein ML; Postema F; Korf J
    J Neural Transm; 1979; 46(4):279-90. PubMed ID: 528999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of probenecid on the free and conjugaed 3-methoxy-4-hydroxyphenylglycol (MHPG) in lumbar cerebrospinal fluid.
    Karoum F; van Kammen DP; Bunney WE; Gillin JC; Jimerson DC; Post RM; Wyatt RJ
    Psychopharmacol Commun; 1976; 2(2):141-8. PubMed ID: 790476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.